Massive divestments loom on the horizon for Singtel: Moody’s

Gains will amount to billions.

Singtel is expected to monetize a number of non-core assets in the near-term in order to pare down its debt, according to a report by Moody’s.

For instance, Singtel needs to monetize its assets in NetLink Trust by April 2018. The value of the assets transferred by Singtel to NetLink Trust is about $2 billion, and Moody's expects Singtel to use part of the divestment proceeds to repay debt.

"Singtel could also monetize its investments in its non-core Singapore associates, including Southern Cross and Singapore Post -- the market capitalization of which was $4.1 billion as of 30 June 2015 (valuing Singtel's stake at about $940 million)," said Nidhi Dhruv, a Moody's Assistant Vice President and lead analyst for Singtel.

Singtel has recently sold its 30% stake in travel services company Abacus Travel Systems for $4.1m (US$3m).

The latent value of Singtel's investments in its regional mobile associates was also significant at about $30.3 billion as of June 2015, more than double its adjusted total debt of $11.8 billion, Moody’s said.


 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

Startups double up on AI tools, Aspire says
Aspire data showed multi-platform usage doubling as spending patterns shift.
65LAB backs NUS biotech venture with $2.13m funding
The capital will help advance a treatment candidate for a chronic lung disease.
Healthcare